药明康德新药开发

药明康德新药开发有限公司于2000年12月成立，是全球领先的制药、生物技术以及医疗器械研发开放式能力和技术平台公司，在中美两国均有运营实体。作为一家以研究为首任，以客户为中心的公司，药明康德向全球制药公司、生物技术公司以及医疗器械公司提供一系列全方位的实验室研发、研究生产服务，服务范围贯穿从药物发现到推向市场的全过程。药明康德的服务旨在通过高性价比、高效率的研发服务帮助全球客户缩短药物及医疗器械研发周期、降低研发成本。ｕ００２６lt；brｕ００２６gt；established in december 2000, wuxi apptec （nyse: wx） is a leading global pharmaceutical, biopharmaceutical, and medical device open-access capability and technology platform with operations in china and the united states. as an innovation-driven and customer-focused company, wuxi apptec provides a broad and integrated portfolio of services throughout the drug rｕ００２６d process. our services are designed to help our worldwide customers shorten the discovery and development time and lower the cost of drug and medical device rｕ００２６d through cost-effective and efficient solutionsｕ００２６lt；brｕ００２６gt；ｕ００２６lt；brｕ００２６gt；